NEWS
-
WARF names Goutham Narla as Chief Scientific Officer of WARF Therapeutics
Physician-scientist and drug discovery leader to guide next phase of translational medicine program CONTACT: Jeanan Yasiri Moe Director of Strategic Communications and Public Affairs [email protected] | (608) 960-9892 MADISON, Wis….
-
Hongmin Chen joins WARF Therapeutics
Chen to head biology for program aiming to produce preclinical candidates CONTACT: Jeanan Yasiri Moe Director of Strategic Communications [email protected] | (608) 960-9892 MADISON, Wis. – WARF Therapeutics, the multimillion-dollar…
-
Industry leaders join WARF Therapeutics Advisory Board
CONTACT: Jeanan Yasiri Moe, Director of Strategic Communications [email protected] | 608.960.9892 Leaders from Celgene, Third Rock Ventures and other top pharma companies will help guide new drug discovery initiative at…
-
Despite the financial risks, new drug discovery vehicles proliferate on campus
Universities bet big on promising therapeutics 6.19.19 | Technology Transfer Tactics | Original Publication | Download the pdf There is nothing like a big hit in the pharmaceutical space to…
EVENTS
No Current Therapeutics Events
For business questions, contact Rafael Diaz. If you are a PI interested in submitting your work to the program or talking through next steps, contact Brian Dyck. You do not need to have a patent; we are interested in talking with you about a new target early in your process.